166 related articles for article (PubMed ID: 26899300)
1. Carfilzomib-induced cardiotoxicity mitigated by dexrazoxane through inhibition of hypertrophic gene expression and oxidative stress in rats.
Al-Harbi NO
Toxicol Mech Methods; 2016; 26(3):189-95. PubMed ID: 26899300
[TBL] [Abstract][Full Text] [Related]
2. Apremilast reversed carfilzomib-induced cardiotoxicity through inhibition of oxidative stress, NF-κB and MAPK signaling in rats.
Imam F; Al-Harbi NO; Al-Harbi MM; Ansari MA; Almutairi MM; Alshammari M; Almukhlafi TS; Ansari MN; Aljerian K; Ahmad SF
Toxicol Mech Methods; 2016 Nov; 26(9):700-708. PubMed ID: 27785949
[TBL] [Abstract][Full Text] [Related]
3. Rutin Attenuates Carfilzomib-Induced Cardiotoxicity Through Inhibition of NF-κB, Hypertrophic Gene Expression and Oxidative Stress.
Imam F; Al-Harbi NO; Al-Harbia MM; Korashy HM; Ansari MA; Sayed-Ahmed MM; Nagi MN; Iqbal M; Khalid Anwer M; Kazmi I; Afzal M; Bahashwan S
Cardiovasc Toxicol; 2017 Jan; 17(1):58-66. PubMed ID: 26707720
[TBL] [Abstract][Full Text] [Related]
4. Cardiac protective effects of dexrazoxane on animal cardiotoxicity model induced by anthracycline combined with trastuzumab is associated with upregulation of calpain-2.
Zhang S; Meng T; Liu J; Zhang X; Zhang J
Medicine (Baltimore); 2015 Jan; 94(4):e445. PubMed ID: 25634181
[TBL] [Abstract][Full Text] [Related]
5. Dose-response relationship of dexrazoxane for prevention of doxorubicin-induced cardiotoxicity in mice, rats, and dogs.
Imondi AR; Della Torre P; Mazué G; Sullivan TM; Robbins TL; Hagerman LM; Podestà A; Pinciroli G
Cancer Res; 1996 Sep; 56(18):4200-4. PubMed ID: 8797592
[TBL] [Abstract][Full Text] [Related]
6. Rutin inhibits carfilzomib-induced oxidative stress and inflammation via the NOS-mediated NF-κB signaling pathway.
Al-Harbi NO; Imam F; Al-Harbi MM; Al-Shabanah OA; Alotaibi MR; As Sobeai HM; Afzal M; Kazmi I; Al Rikabi AC
Inflammopharmacology; 2019 Aug; 27(4):817-827. PubMed ID: 30600471
[TBL] [Abstract][Full Text] [Related]
7. Zingerone Attenuates Carfilzomib-Induced Cardiotoxicity in Rats through Oxidative Stress and Inflammatory Cytokine Network.
Alam MF; Hijri SI; Alshahrani S; Alqahtani SS; Jali AM; Ahmed RA; Adawi MM; Algassmi SM; Shaheen ES; Moni SS; Anwer T
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555257
[TBL] [Abstract][Full Text] [Related]
8. Protection against doxorubicin-induced cardiotoxicity in weanling rats by dexrazoxane.
Della Torre P; Mazué G; Podestà A; Moneta D; Sammartini U; Imondi AR
Cancer Chemother Pharmacol; 1999; 43(2):151-6. PubMed ID: 9923821
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective effect of dexrazoxane in a rat model of myocardial infarction: anti-apoptosis and promoting angiogenesis.
Zhou L; Sung RY; Li K; Pong NH; Xiang P; Shen J; Ng PC; Chen Y
Int J Cardiol; 2011 Oct; 152(2):196-201. PubMed ID: 20692056
[TBL] [Abstract][Full Text] [Related]
10. Protective Effects of Dexrazoxane against Doxorubicin-Induced Cardiotoxicity: A Metabolomic Study.
QuanJun Y; GenJin Y; LiLi W; YongLong H; Yan H; Jie L; JinLu H; Jin L; Run G; Cheng G
PLoS One; 2017; 12(1):e0169567. PubMed ID: 28072830
[TBL] [Abstract][Full Text] [Related]
11. Oxyphenbutazone ameliorates carfilzomib induced cardiotoxicity in rats via inhibition of oxidative free radical burst and NF-κB/IκB-α pathway.
Imam F; Afzal M; Ghaboura N; Saad Alharbi K; Kazmi I; Alshehri S; Saeed Alqarni S; Guven E
Saudi Pharm J; 2024 Jan; 32(1):101926. PubMed ID: 38226350
[TBL] [Abstract][Full Text] [Related]
12. A possible antineoplastic potential of selective, irreversible proteasome inhibitor, carfilzomib on chemically induced hepatocarcinogenesis in rats.
Mansour MA; Aljoufi MA; Al-Hosaini K; Al-Rikabi AC; Nagi MN
J Biochem Mol Toxicol; 2014 Sep; 28(9):400-6. PubMed ID: 24861196
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotection by dexrazoxane in rats treated with doxorubicin and paclitaxel.
Della Torre P; Imondi AR; Bernardi C; Podestà A; Moneta D; Riflettuto M; Mazué G
Cancer Chemother Pharmacol; 1999; 44(2):138-42. PubMed ID: 10412948
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of cardiotoxicity of gefitinib in vivo and in vitro rat cardiomyocyte: Role of apoptosis and oxidative stress.
Korashy HM; Attafi IM; Ansari MA; Assiri MA; Belali OM; Ahmad SF; Al-Alallah IA; Anazi FE; Alhaider AA
Toxicol Lett; 2016 Jun; 252():50-61. PubMed ID: 27084042
[TBL] [Abstract][Full Text] [Related]
15. Ellagic acid protects against arsenic trioxide-induced cardiotoxicity in rat.
Hemmati AA; Olapour S; Varzi HN; Khodayar MJ; Dianat M; Mohammadian B; Yaghooti H
Hum Exp Toxicol; 2018 Apr; 37(4):412-419. PubMed ID: 28474970
[TBL] [Abstract][Full Text] [Related]
16. Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis.
Mantawy EM; El-Bakly WM; Esmat A; Badr AM; El-Demerdash E
Eur J Pharmacol; 2014 Apr; 728():107-18. PubMed ID: 24509133
[TBL] [Abstract][Full Text] [Related]
17. Thymoquinone Ameliorates Carfilzomib-Induced Renal Impairment by Modulating Oxidative Stress Markers, Inflammatory/Apoptotic Mediators, and Augmenting Nrf2 in Rats.
Qadri MM; Alam MF; Khired ZA; Alaqi RO; Khardali AA; Alasmari MM; Alrashah ASS; Muzafar HMA; Qahl AM
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445797
[TBL] [Abstract][Full Text] [Related]
18. Dexrazoxane prevents doxorubicin-induced long-term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats.
Lebrecht D; Geist A; Ketelsen UP; Haberstroh J; Setzer B; Walker UA
Br J Pharmacol; 2007 Jul; 151(6):771-8. PubMed ID: 17519947
[TBL] [Abstract][Full Text] [Related]
19. Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model.
Xiang P; Deng HY; Li K; Huang GY; Chen Y; Tu L; Ng PC; Pong NH; Zhao H; Zhang L; Sung RY
Cancer Chemother Pharmacol; 2009 Jan; 63(2):343-9. PubMed ID: 18379782
[TBL] [Abstract][Full Text] [Related]
20. Diminished molecular response to doxorubicin and loss of cardioprotective effect of dexrazoxane in Egr-1 deficient female mice.
Saadane N; Yue P; Alpert L; Mitmaker B; Kirby GM; Chalifour LE
Can J Physiol Pharmacol; 2001 Jun; 79(6):533-44. PubMed ID: 11430591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
